Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Casirivimab Emergency use authorization Experimental Antiviral Jan/26/2022 4 11
Imdevimab Emergency use authorization Experimental Antiviral Jan/26/2022 9 8
N(4)-Hydroxycytidine Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022 5 0
Molnupiravir Emergency use authorization Experimental Antiviral Jan/20/2022 14 1